Ireland[爱尔兰药品]

Vesomni 6 mg/0.4 mg modified release tablets

1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadministration 4.3Contr..

录入者：admin 发表于：2014-12-08 　查阅全文...

INSPRA 25 mg film-coated tablets.INSPRA 50 mg film-coated ta

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-12-08 　查阅全文...

Victrelis 200 mg hard capsules

1.Nameofthemedicinalproduct Victrelis200mghardcapsules 2.Qualitativeandquantitativecomposition Eachhardcapsulecontains200mgofboceprevir. Excipientwithknowneffe..

录入者：admin 发表于：2014-12-04 　查阅全文...

Vipidia 6.25mg, 12.5mg, 25mg film-coated tablets

1.Nameofthemedicinalproduct Vipidia6.25mgfilm-coatedtablets Vipidia12.5mgfilm-coatedtablets Vipidia25mgfilm-coatedtablets 2.Qualitativeandquantitativecomposition Eachtabletcontainsalog..

录入者：admin 发表于：2014-12-03 　查阅全文...

SIRTURO 100 mg tablets(结核病新药)

2014年3月7日，强生结核病新药Situro（bedaquiline）获欧盟委员会（EC）有条件批准（conditionalapproval），作为组合疗法的一部分，用于因耐药性或耐受性使得一种有效治疗方案不能用于其临床治疗的肺部耐多药..

录入者：admin 发表于：2014-12-02 　查阅全文...

Telfast 120mg film-coated tabletsfexofenadine hydrochloride

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-12-02 　查阅全文...

Telfast 180mg film-coated Tabletsfexofenadine hydrochloride

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-12-02 　查阅全文...

Norvir 100 mg film-coated tabletsRitonavir

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-11-23 　查阅全文...

Norvir 80 mg/ml oral solutionRitonavir

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-11-23 　查阅全文...

Mestinon 60mg TabletsPyridostigmine Bromide

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-11-20 　查阅全文...

Mestinon 60mg TabletsPyridostigmine Bromide

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-11-20 　查阅全文...

Bridion 100 mg/ml solution for injectionSugammadex sodium

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-11-20 　查阅全文...

Flagyl Suppositories 0.5g.Metronidazole

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-11-16 　查阅全文...

Flagyl 200mg Tablets.Flagyl 400mg Tablets.Metronidazole

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-11-16 　查阅全文...

Flagyl-S 200mg/5ml Oral Suspension.Metronidazole benzoate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2014-11-16 　查阅全文...

Flagyl 0.5%w/v Solution for Infusion in Viaflex Container.Me

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-11-16 　查阅全文...

CILEST 250/35 microgram TabletsEthinyloestradiolNorgestimate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-11-14 　查阅全文...

Symbicort Turbohaler 100 micrograms/6 micrograms/inhalation,

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-11-09 　查阅全文...

Symbicort Turbohaler 400 micrograms/12 micrograms/inhalation

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-11-09 　查阅全文...

BYDUREON 2 mg powder and solvent for prolonged-release suspe

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-11-09 　查阅全文...

首页上一页 32 33 34 35 36 37 38 下一页尾页 35/66/1301